Eric Converse

Favonius Ventures Ltd. is the UK representative office of the European venture capital firm Favonius Ventures, which was founded by Roel Pieper and Jan de Jong in 2001 and is based in Amsterdam. In 2006 ABN AMRO Capital, the private equity business unit of ABN AMRO Bank NV, transferred the management of their technology investment portfolio to Favonius.

Oblicore, Inc. provides service level management software. Its flagship product, Oblicore automates, activates and accelerates the monitoring, reporting, and management of the service portfolio and service level agreements for enterprises and service providers. The company was founded in 2000 and is headquartered in Waltham, MA.

CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA.

VirtualScopics, Inc. provides quantitative imaging solutions currently serving the pharmaceutical, biotechnology and medical device industries. It provides image analysis software tools and applications which are used in detecting and measuring specific anatomical structures and metabolic activity using medical images. The company's therapeutic area expertise includes oncology, rheumatoid arthritis, osteoarthritis, neurology, cardiovascular, muscle and fat measurements and COPD studies utilizing MRI, PET, CT, Ultrasound and X-Ray imaging modalities. VirtualScopics was founded by Saara Totterman, Kevin J. Parker, Jose Tamez-Pena and Edward Ashton in July 2000 and is headquartered in Rochester, NY.

Converse & Co., Inc. supplies energy equipment and solutions. The company is headquartered in Spartanburg, SC.

Nedamco International BV is a Private Equity/Venture Capital firm, a subsidiary of Verder International BV founded in 2014. Pindustry BV is headquartered in Bloemendaal.

Advanced MR Analytics AB offers solutions for body composition analysis. It transforms subjective magnetic resonance images into fat and muscle measurements. The firm provides technical research such as data acquisition and reconstruction; registration and fusion; machine learning and signal representation; modelling and simulation; simulation, classification, and quantification; visualization and image enhancement; and user interfaces and interaction. The company was founded by David Magnus Borga and Olof Erik Gunnar Dahlqvist Leinhard in 2010 and is headquartered in Link?ping, Sweden.

PreciseDx Ltd. is a British AI company that specializes in oncology diagnostics. The company is based in Altrincham, UK. The company leverage the analysis of morphology features from histology slides to provide more precise patient-specific risk information. The company's proprietary morphology feature array™ allows clinical teams to have access to unmatched insights and accurate, actionable intelligence for disease state characterization to determine the best treatment for each patient. PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making. The company was founded in 2019. Wayne L. Brinster has been the CEO of the company since 2021.